Filing Flows › Protagonist Therapeutics (PTGX) › How it makes money
How Protagonist Therapeutics (PTGX) makes money
Protagonist Therapeutics (PTGX) made $274M of revenue in the third quarter 2026 (Q3 2026), up 58-fold from a year earlier. Of every dollar of revenue, 80¢ was left as operating profit, 80¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $274M | 100.0% |
| Operating profit | $218M | 79.6% |
| Income tax | $6.6M | 2.4% |
| Net earnings | $220M | 80.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $274M | 58× |
| Q2 2026 | $213M | 38× |
| Q1 2026 | $56.4M | +99% |
| Q4 2025 | $7.4M | -96% |
| Q3 2025 | $4.7M | +0.8% |
| Q2 2025 | $5.5M | +33% |
| Q1 2025 | $28.3M | -89% |
From Protagonist Therapeutics' 10-Q filed Nov 6, 2026 (on EDGAR).
Questions
How does Protagonist Therapeutics make money?
Protagonist Therapeutics (PTGX) made $274M of revenue in the third quarter 2026 (Q3 2026), up 58-fold from a year earlier. Of every dollar of revenue, 80¢ was left as operating profit, 80¢ was left as net earnings.
What is Protagonist Therapeutics' profit margin?
Net earnings were $220M, 80.2% of revenue, in the third quarter 2026; the operating margin was 79.6%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.